Cargando…
Therapeutic effects of lornoxicam-loaded nanomicellar formula in experimental models of rheumatoid arthritis
BACKGROUND: Rheumatoid arthritis (RA) is a chronic inflammatory disease treated by nonsteroidal anti-inflammatory drugs (NSAIDs) including lornoxicam (LX). Nanocarriers have been used to increase the efficacy and reduce the side effects of various drugs. The objective of the present study was to com...
Autores principales: | Helmy, Hebatullah Samy, El-Sahar, Ayman E, Sayed, Rabab H, Shamma, Rehab Nabil, Salama, Alaa Hamed, Elbaz, Eman Maher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626385/ https://www.ncbi.nlm.nih.gov/pubmed/29026298 http://dx.doi.org/10.2147/IJN.S147738 |
Ejemplares similares
-
Nanomicellar Extraction of Polyphenols—Methodology and Applications Review
por: Śliwa, Paweł, et al.
Publicado: (2021) -
Matrix-mini-tablets of lornoxicam for targeting early morning peak symptoms of rheumatoid arthritis
por: Mohd, Abdul Hadi, et al.
Publicado: (2014) -
Effects of lornoxicam on the physiology of severe sepsis
por: Memiş, Dilek, et al.
Publicado: (2004) -
Lornoxicam-Loaded Chitosan-Decorated Nanoemulsion: Preparation and In Vitro Evaluation for Enhanced Transdermal Delivery
por: Khan, Rahman Ullah, et al.
Publicado: (2022) -
Perorally active nanomicellar formulation of quercetin in the treatment of lung cancer
por: Tan, Bee-Jen, et al.
Publicado: (2012)